![](/img/cover-not-exists.png)
Canakinumab treat-to target strategies increase complete response rate in CAPS
Kuemmerle-Deschner, J, Hofer, F, Endres, T, Kortus-Goetze, B, Blank, N, Weißbarth-Riedel, E, Schuetz, C, Kallinich, T, Krause, K, Rietschel, C, Horneff, G, Benseler, SMVolume:
13
Year:
2015
Language:
english
Journal:
Pediatric Rheumatology
DOI:
10.1186/1546-0096-13-S1-P173
File:
PDF, 226 KB
english, 2015